Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Authors
Keywords
-
Journal
NATURE
Volume 558, Issue 7711, Pages 540-546
Publisher
Springer Nature
Online
2018-06-11
DOI
10.1038/s41586-018-0217-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER + /HER2 − Metastatic Breast Cancer
- (2016) Ingrid A. Mayer et al. CLINICAL CANCER RESEARCH
- Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans
- (2016) Sandra D. Castillo et al. Science Translational Medicine
- Heterozygous expression of the oncogenic Pik3caH1047R mutation during murine development results in fatal embryonic and extraembryonic defects
- (2015) Lauren M. Hare et al. DEVELOPMENTAL BIOLOGY
- Ubiquitous expression of the Pik3caH1047R mutation promotes hypoglycemia, hypoinsulinemia, and organomegaly
- (2015) Kathryn M. Kinross et al. FASEB JOURNAL
- PIK3CA-related overgrowth spectrum (PROS): Diagnostic and testing eligibility criteria, differential diagnosis, and evaluation
- (2014) Kim M. Keppler-Noreuil et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Clinical delineation and natural history of thePIK3CA-related overgrowth spectrum
- (2014) Kim M. Keppler-Noreuil et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Characterization of the Novel and Specific PI3K Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials
- (2014) C. Fritsch et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome
- (2014) Guillaume Canaud et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation
- (2013) Pascal Furet et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- AKT2 is essential to maintain podocyte viability and function during chronic kidney disease
- (2013) Guillaume Canaud et al. NATURE MEDICINE
- Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES Syndrome
- (2012) Kyle C. Kurek et al. AMERICAN JOURNAL OF HUMAN GENETICS
- PI3K signalling: the path to discovery and understanding
- (2012) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Sirolimus for the treatment of complicated vascular anomalies in children
- (2011) Adrienne M. Hammill et al. PEDIATRIC BLOOD & CANCER
- PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
- (2009) Lakshmi Srinivasan et al. CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now